» Articles » PMID: 19900967

IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a Database and a Tool for Immunoglobulins or Antibodies, T Cell Receptors, MHC, IgSF and MhcSF

Overview
Specialty Biochemistry
Date 2009 Nov 11
PMID 19900967
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

IMGT/3Dstructure-DB is the three-dimensional (3D) structure database of IMGT, the international ImMunoGenetics information system that is acknowledged as the global reference in immunogenetics and immunoinformatics. IMGT/3Dstructure-DB contains 3D structures of immunoglobulins (IG) or antibodies, T cell receptors (TR), major histocompatibility complex (MHC) proteins, antigen receptor/antigen complexes (IG/Ag, TR/peptide/MHC) of vertebrates; 3D structures of related proteins of the immune system (RPI) of vertebrates and invertebrates, belonging to the immunoglobulin and MHC superfamilies (IgSF and MhcSF, respectively) and found in complexes with IG, TR or MHC. IMGT/3Dstructure-DB data are annotated according to the IMGT criteria, using IMGT/DomainGapAlign, and based on the IMGT-ONTOLOGY concepts and axioms. IMGT/3Dstructure-DB provides IMGT gene and allele identification (CLASSIFICATION), region and domain delimitations (DESCRIPTION), amino acid positions according to the IMGT unique numbering (NUMEROTATION) that are used in IMGT/3Dstructure-DB cards, results of contact analysis and renumbered flat files. In its Web version, the IMGT/DomainGapAlign tool analyses amino acid sequences, per domain. Coupled to the IMGT/Collier-de-Perles tool, it provides an invaluable help for antibody engineering and humanization design based on complementarity determining region (CDR) grafting as it precisely defines the standardized framework regions (FR-IMGT) and CDR-IMGT. IMGT/3Dstructure-DB and IMGT/DomainGapAlign are freely available at http://www.imgt.org.

Citing Articles

abnization platform: A monoclonal antibody heterologization server based on rational design and artificial intelligence-assisted computation.

Hao X, Liu D, Fan L Comput Struct Biotechnol J. 2024; 23:3222-3231.

PMID: 39660217 PMC: 11630649. DOI: 10.1016/j.csbj.2024.08.013.


RankMHC: Learning to Rank Class-I Peptide-MHC Structural Models.

Fasoulis R, Paliouras G, Kavraki L J Chem Inf Model. 2024; 64(23):8729-8742.

PMID: 39555889 PMC: 11633655. DOI: 10.1021/acs.jcim.4c01278.


Using IMGT unique numbering for IG allotypes and Fc-engineered variants of effector properties and half-life of therapeutic antibodies.

Lefranc M, Lefranc G Immunol Rev. 2024; 328(1):473-506.

PMID: 39367563 PMC: 11659927. DOI: 10.1111/imr.13399.


An updated AL-Base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.

Morgan G, Nau A, Wong S, Spencer B, Shen Y, Hua A bioRxiv. 2024; .

PMID: 39314448 PMC: 11419035. DOI: 10.1101/2024.09.11.612490.


Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework.

Kassardjian A, Ivanochko D, Barber B, Jetha A, Julien J Antibodies (Basel). 2024; 13(3).

PMID: 39051333 PMC: 11270187. DOI: 10.3390/antib13030057.


References
1.
Garapati V, Lefranc M . IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors. Dev Comp Immunol. 2007; 31(10):1050-72. DOI: 10.1016/j.dci.2007.01.008. View

2.
Pelat T, Bedouelle H, Rees A, Crennell S, Lefranc M, Thullier P . Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol. 2008; 384(5):1400-7. DOI: 10.1016/j.jmb.2008.10.033. View

3.
Lefranc M, Pommie C, Kaas Q, Duprat E, Bosc N, Guiraudou D . IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev Comp Immunol. 2004; 29(3):185-203. DOI: 10.1016/j.dci.2004.07.003. View

4.
Lefranc M, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L . IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol. 2002; 27(1):55-77. DOI: 10.1016/s0145-305x(02)00039-3. View

5.
Magdelaine-Beuzelin C, Kaas Q, Wehbi V, Ohresser M, Jefferis R, Lefranc M . Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment. Crit Rev Oncol Hematol. 2007; 64(3):210-25. DOI: 10.1016/j.critrevonc.2007.04.011. View